The summer of 2023 saw the approval of a new treatment option for certain patients with uveal melanoma, a form of cancer that begins in the eye and remains a challenge to treat. Richard Staines ...

Turnstone, which went public via an $80 million IPO in 2023, ended September 2024 with $45.3 million to hand, which the company had been expecting to last into the second quarter of 2026.

After hours: January 31 at 6:55:48 PM EST Loading Chart for REPL ...

The healthcare industry is set for growth due to advancements in targeted treatments and personalized care and the rapid ...

SAN DIEGO - Turnstone Biologics Corp. (NASDAQ:TSBX), a clinical-stage biotechnology company with a market capitalization of $9.45 million, has announced the discontinuation of its TIDAL-01 clinical ...

Trusted resource of information on Medical Oncology that includes articles, news, diet & nutrition, multimedia presentations, ...

Shares of Immunocore Holdings plc (NASDAQ:IMCR – Get Free Report) have received an average recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the firm, ...

Do you have blue eyes? We talked to experts to discover curious facts about baby blues, including whether your biological family is bigger than you ever imagined.

The disciplines of pharmacology and physiology touch on virtually every field of the biomedical sciences, presenting endless opportunities to discover disease mechanisms and develop new treatments.

Daily science news on research developments and the latest scientific innovations Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech ...

Trusted resource of information on Cancer that includes articles, news, videos, animations, quizzes, calculators and drugs.